The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement

4 Sep 2012 10:00

RNS Number : 4386L
Microsaic Systems plc
04 September 2012
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Microsaic's International Partner to present its new Mass Directed Flash System at JASIS 2012

4 September 2012 

Microsaic Systems plc (AIM: MSYS), today announces that Biotage AB (Uppsala, Sweden), a leading global supplier of laboratory equipment, will be presenting its fully integrated solution for 'Mass Directed Flash' purification at JASIS 2012 (Japan Analytical Scientific Instruments Show) in Makuhari Messe, Japan (5-7 September). This is the first time Biotage has presented the new system, which incorporates Microsaic's novel miniature mass spectrometer - the Microsaic MiD.

Microsaic entered an agreement in May 2012 with Biotage, previously identified in announcements as 'an international supplier of laboratory equipment',to provide its MiD chip-based scientific instrument as an Original Equipment Manufacturer (OEM). Since then, Microsaic has further developed the MiD and the companies are at an advanced stage of integrating it with Biotage's flagship Flash purification system Isolera™. The new integrated system is expected to be commercially available in early 2013.

Mass directed flash purification is a powerful technique for collecting compounds based on mass allowing the chemist to purify and analyse compounds at the same time.

Eric Yeatman, Chief Executive of Microsaic Systems, commented:

"One of Microsaic's key strategic aims is to grow sales of our innovative products as an OEM partner with leading international suppliers of scientific instruments in specified application areas of chemical separation and purification. Our objective is to benefit from access to an existing customer base and also to make mass spectrometry available to a wide range of new customers and to open new opportunities. We are very pleased at the progress being made with Biotage, which matches unique benefits of our miniaturised instruments with their product development and international commercial capabilities."

Toshiyuki Yachi, Vice President Marketingof Biotage, added:

"This is a game changer in flash purification that will allow chemists to significantly improve their work flow. We have high expectations on the forthcoming launch of this product that will further strengthen our purification business."

Contacts

Microsaic Systems

Eric Yeatman, CEO

 

Via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Malcolm Robertson, Chris Gardner

 

+44 (0)20 7282 2995/2948

The Scott Partnership (Trade PR)

Sarah Evans

+44 (0)1477 539540

 

 

 

About Microsaic Systems

 

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

 

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

 

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

 

www.microsaic.com

 

About Biotage

 

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world's top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 428.4 MSEK in 2011. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIGDCSSGBGDS
Date   Source Headline
11th Aug 20209:30 amRNSForm 8.5 (EPT/RI)
10th Aug 20204:33 pmBUSForm 8.3 - Microsaic Systems
10th Aug 202010:08 amRNSForm 8.5 (EPT/RI)
7th Aug 20204:59 pmRNSForm 8.3 - Microsaic Systems PLC
7th Aug 20209:14 amRNSForm 8.5 (EPT/RI)
6th Aug 202012:07 pmRNSForm 8.5 (EPT/RI)
5th Aug 202010:04 amRNSForm 8.5 (EPT/RI)
4th Aug 20202:31 pmRNSForm 8.3 - Microsaic Systems PLC
4th Aug 202011:39 amRNSForm 8.5 (EPT/RI)
3rd Aug 20201:54 pmRNSForm 8.3 - Microsaic Systems plc
3rd Aug 202011:24 amRNSForm 8.5 (EPT/RI)
31st Jul 20204:06 pmRNSForm 8 (OPD) Microsaic Systems plc
31st Jul 20201:43 pmRNSForm 8.3 - Microsaic Systems plc
31st Jul 20209:37 amRNSForm 8.5 (EPT/RI)
31st Jul 20209:11 amRNSForm 8.3 - Microsaic Systems plc
30th Jul 20204:03 pmRNSParkwalk Advisors: Form 8.3- Microsaic Systems plc
30th Jul 202011:47 amRNSForm 8.5 (EPT/RI)
29th Jul 20205:48 pmGNWForm 8.3 - Microsaic Systems plc
29th Jul 202012:00 pmRNSForm 8.3 - Microsaic Systems plc
29th Jul 20207:00 amRNSStrategic Review and Formal Sale Process
25th Jun 20203:16 pmRNSResult of AGM
1st Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20207:00 amRNSCOVID-19 Update
9th Mar 20207:00 amRNSFinal Results
3rd Mar 20207:00 amRNSAppointment of WH Ireland as Joint Broker
26th Feb 20207:00 amRNSGlobal collaboration agreement with Axcend Corp
16th Jan 20207:00 amRNSPre-close Trading Update
16th Dec 20197:00 amRNSMicrosaic collaborates with the CPI
6th Dec 20194:35 pmRNSPrice Monitoring Extension
5th Dec 20199:05 amRNSSecond Price Monitoring Extn
5th Dec 20199:00 amRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSExclusive Japan Distribution Agreement
13th Nov 20194:41 pmRNSSecond Price Monitoring Extn
13th Nov 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.